Wednesday, August 23, 2017| Acquisitions, Mergers, Carl Zeiss Meditec, Nidek, Product Releases

EyewireTV — Retinal Imaging for Alzheimer’s; Zeiss Acquisition

In this week’s EyewireTV, a new study shows that noninvasive retinal imaging may detect the pathological hallmarks of Alzheimer’s disease; and Carl Zeiss Meditec acquires Veracity Innovations, maker of a cloud-based platform that provides eye doctors access to clinical data at each step in the treatment regimen. Also, Nidek announces the launch of the the TS-310, a tabletop subjective refraction system that combines refractor and chart capabilities in a compact footprint.

Watch Video

Wednesday, August 16, 2017

EyewireTV — Solar Eclipse Safety; Eyetube3D Launches

As Americans prepare for the first total solar eclipse in the United States in 37 years, EyewireTV provides tips on how to safely view the rare event and advice to physicians who may see patients with solar retinopathy; and a year after launching in the United States, Shire applies for European approval for its blockbuster dry eye drug lifitegrast. Also, Eyetube announces the launch of Eyetube3D, a new channel that allows physicians with a virtual reality headset to view 3-dimensional surgical cases online.

Watch Video

Wednesday, August 09, 2017| Cornea, FDA Approval/Clearance, Intraocular Pressure, IOP, Johnson & Johnson Vision Care, Meibomian Gland Dysfunction, MGD, Optovue, TearScience, Valeant

EyewireTV — J&J Agrees To Buy TearScience; FDA Clears Epi-Mapping Software

In this week’s EyewireTV, Johnson & Johnson Vision continues to boost its eye care portfolio as it announces a definitive agreement to acquire TearScience, a provider of devices that detect and treat meibomian gland dysfunction; and the FDA rejects Valeant's new drug application for IOP-lowering eye drop latanoprostene bunod, citing manufacturing issues. Also, the FDA clears Optovue's epithelial thickness mapping software (epi-mapping) for quantitative measurements of the epithelial and stromal layers of the cornea.

Watch Video

Wednesday, August 02, 2017| Cataract, FDA Approval/Clearance, Guardian Health Sciences, Intravitreal Injection, Photocoagulation, Quantel Medical

EyewireTV — FDA Safety Alert for Intravitreal Compounded Drug; Easyret Approved in US

In this week’s EyewireTV, the FDA issues a safety alert after at least 43 patients who received intravitreal injections of a compounded drug from Guardian Pharmacy Services in Dallas suffered serious adverse events; and a recent study published in JAMA Ophthalmology reveals that high vitamin K1 intake reduces cataract formation in an elderly Mediterranean population. Also, Quantel Medical receives FDA approval for the Easyret fully integrated 577-nm yellow photocoagulator, which is used to treat certain forms of macular edema and peripheral retinal pathologies.

Watch Video

Wednesday, July 26, 2017| Dompé, Dry Eye, neurotrophic keratitis, TearLab Corp., TearLab Discovery System

EyewireTV - Dry Eye Disease Redefined; New TearLab Platform

In this week’s Eyewire, the Tear Film & Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) II report is published, updating the definition of dry eye disease; and TearLab receives CE Mark approval for its next-generation, in-vitro diagnostics testing platform, the TearLab Discovery System. Also, Dompé announces that the European Commission has granted marketing authorization of its cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis.

Watch Video

Wednesday, July 12, 2017| Blepharoplasty, FDA Approval/Clearance, Glaucoma, Inotek Pharmaceuticals, Intraocular Pressure, IOP, IOPtima, Ocular Therapeutix

EyewireTV — FDA Rejects Dextenza Again; Blepharoplasty System Launched

In this week’s EyewireTV, for the second time, the FDA does not approve Ocular Therapeutix's NDA for Dextenza, citing manufacturing deficiencies; and IOPtima announces the launch of the iLid CO2 laser-assisted blepharoplasty kit. Also, in a phase 2 trial, Inotek Pharmaceuticals’ glaucoma candidate fails to show a clinical advantage in IOP reduction after 4 weeks.

Watch Video
Load More